Related Experiment Video For RCS
Updated: Jan 12, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Association between the triglyceride-glucose index and hyperuricemia in patients with type 2 diabetes mellitus
Xu Sun1,2,3, Xin Li1,2, Zhuyin Qian4
1Department of Pharmacy, Nanjing Luhe People's Hospital, Nanjing, China.
Aim:
This cross-sectional study investigated the relationship between the triglyceride-glucose (TyG: A surrogate marker for assessing insulin resistance.) index and hyperuricemia (HUA: Metabolic diseases caused by purine metabolism disorders.) risk in Chinese patients with type 2 diabetes mellitus (T2DM).
Methods:
From January 2021 to December 2023, T2DM patients were enrolled from Luhe District People's Hospital in Nanjing. Participants were stratified by TyG index quartiles. Logistic regression and restricted cubic spline (RCS) analyses assessed the TyG-HUA association.
Results:
This study included 996 participants with type 2 diabetes, with a male predominance of 54.82%, a mean age of 60.39 years, and a median TyG index of 7.63. Compared to the lowest TyG quartile, the highest quartile exhibited a 4.23-fold (95% CI: 1.46 ~ 12.24, P value = 0.008) increased HUA risk. Restricted cubic spline analysis revealed a nonlinear relationship between the TyG index and HUA (nonlinear P value = 0.044). As the TyG level increased, the risk of HUA initially rose and then showed a downward trend (P for TyG = 0.008).
Conclusions:
Elevated TyG index independently predicts HUA risk in T2DM patients. Early metabolic intervention may mitigate HUA-related cardiovascular morbidity and mortality.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Sulfonylureas
Hypoglycemia and Glucagon